Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canvax Biotech is a private Spanish life sciences company that develops and manufactures enzymes, recombinant proteins, buffers, PCR and qPCR reagents, extraction kits, cell-based assays, and related molecular biology products for research, diagnostic, and clinical applications. The company also provides custom biomanufacturing and custom liquids services, including RUO, IVD, and clinical-grade/GMP-oriented production for biotech and pharmaceutical customers. Historically, Canvax has conducted R&D in multiplex high-throughput screening platforms, diagnostic biosensors, and GPCR expression technologies, including odorant receptor expression systems. Its business appears to be primarily centered on commercial life science reagents and contract manufacturing rather than a traditional therapeutic drug pipeline. The company operates certified manufacturing facilities in Valladolid, Spain and distributes products internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canvax Biotech.